Announcements

Announcements

 

Paul G. Allen Frontiers Group [to 19 Oct 2019]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BMGF – Gates Foundation [to 19 Oct 2019]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 19 Oct 2019]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 19 Oct 2019]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 19 Oct 2019]
http://cepi.net/
News
Faster, more agile vaccine tech needed to fight tomorrow’s epidemics
15 Oct 2019 By Richard Hatchett
[See Milestones/Perspectives above for detail]

 

Clinton Health Access Initiative, Inc. (CHAI) [to 19 Oct 2019]
https://clintonhealthaccess.org/about/
News & Press Releases
No new digest content identified.

 

EDCTP [to 19 Oct 2019]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
17 October 2019
Annual Report 2018 – a strong portfolio halfway EDCTP2
EDCTP published its Annual Report 2018 – 15th anniversary of the EDCTP programme in a new digital format. The report gives a quick overview of the milestones in the development of the partnership since 2003 and presents the strong EDCTP2…

 

Emory Vaccine Center [to 19 Oct 2019]
http://www.vaccines.emory.edu/
No new digest content identified.

 

European Medicines Agency [to 19 Oct 2019]
http://www.ema.europa.eu/ema/
Press release: First vaccine to protect against Ebola
CHMP, Last updated: 18/10/2019
EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation in the European Union for Ervebo (rVSVΔG-ZEBOV-GP), the first vaccine for active immunisation of individuals aged 18 years and older at risk of infection with the Ebola virus.
“This is an important step towards relieving the burden of this deadly disease,” said Guido Rasi, EMA’s Executive Director. “The CHMP’s recommendation is the result of many years of collaborative global efforts to find and develop new medicines and vaccines against Ebola. Public health authorities in countries affected by Ebola need safe and efficacious medicines to be able to respond effectively to outbreaks and save lives.”…

News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2019
CHMP, Last updated: 18/10/2019

Press release: European countries increase commitment to responsible antibiotic use in animals
Last updated: 15/10/2019

 

European Vaccine Initiative [to 19 Oct 2019]
http://www.euvaccine.eu/news-events
No new digest content identified.

 

FDA [to 19 Oct 2019]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
October 16, 2019 – Statement on continued progress enhancing patient access to high-quality, low-cost generic drugs
FDA generic drug approvals reach record high in fiscal year 2019
Affordable access to medicines is a public health concern and more generic drug competition can help reduce prices, improve access and benefit the public health. Safe, effective and high-quality generic drugs play a vital role in our health care system. Generic drugs account for about 90% of all prescription drug purchases in the U.S. In 2018, competition from generic drugs saved the health care system about $293 billion.
Thanks to the FDA’s ongoing efforts under the Drug Competition Action Plan and the Generic Drug User Fee Amendments, the FDA has built a thriving generic drug program that continues to impress me. I am pleased to report that our generic drug program is having another strong year…

 

Fondation Merieux [to 19 Oct 2019]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

 

Gavi [to 19 Oct 2019]
https://www.gavi.org/
Latest news
Kenya introduces cervical cancer vaccine nationally  
Approximately 800,000 girls to be protected annually through introduction of HPV vaccine into routine immunisation programme
Mombasa, 18 October 2019 – Around 800,000 girls across Kenya will be protected against cervical cancer annually following the introduction of human papillomavirus (HPV) vaccine into the country’s routine immunisation programme, Kenya’s Cabinet Secretary for Health Sicily Karuiki announced today at a launch ceremony in Mombasa County.

“Scaling up access to quality health services, particularly for women and girls, is a critical part of Kenya’s Big Four Action Plan,” said Sicily Karuiki. “Cervical cancer is the leading cause of female cancer deaths in Kenya. Working with partners like Gavi, UNICEF and WHO to introduce HPV vaccine into our routine immunisation programme is an important step forward in ensuring the health and long-term prosperity of the Kenyan people.”
The vaccines, provided through support from Gavi, the Vaccine Alliance, will aim to reach all girls aged 10 in two doses administered six months apart…

 

GHIT Fund [to 19 Oct 2019]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

 

Global Fund [to 19 Oct 2019]
https://www.theglobalfund.org/en/news/
News & Stories
News
Sharp Upturn Achieved in Finding People with TB
17 October 2019

Voices
How We Can Secure the Broadest Access to Quality-Assured and Affordable Medicines to Defeat HIV
16 October 2019

 

Hilleman Laboratories [to 19 Oct 2019]
http://www.hillemanlabs.org/
No new digest content identified.

 

Human Vaccines Project [to 19 Oct 2019]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.

 

IAVI [to 19 Oct 2019]
https://www.iavi.org/newsroom
No new digest content identified.

 

 

International Coalition of Medicines Regulatory Authorities (ICMRA)
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.

 

IFRC [to 19 Oct 2019]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 

IVAC [to 19 Oct 2019]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.

 

IVI [to 19 Oct 2019]
http://www.ivi.int/
Selected IVI News & Announcements
IVI and the USask’s VIDO-InterVac Exchange MOU to Advance Vaccine Research
October 16, 2019, SEOUL, Korea — IVI and the University of Saskatchewan’s (USask) VIDO-InterVac, a global leader in infectious disease research and vaccine development, exchanged a memorandum of understanding (MOU) at IVI headquarters to establish future partnership in vaccine research and capacity-building…
The VIDO-InterVac works with international partners to develop solutions for human and animal pathogens, and has commercialized eight vaccine technologies, six of which are world firsts. With this mutual understanding, the university research institute and IVI will take steps to exchange knowledge and opportunities for the shared mission of advancing vaccines…

 

JEE Alliance [to 19 Oct 2019]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 19 Oct 2019]
http://www.msf.org/
Latest [Selected Announcements]
Syria
Northeast Syria: MSF forced to evacuate staff due to extreme volatilit…
Press Release 14 Oct 2019

 

National Vaccine Program Office – U.S. HHS [to 19 Oct 2019]
https://www.hhs.gov/vaccines/about/index.html
No new digest content identified.

 

NIH [to 19 Oct 2019]
http://www.nih.gov/news-events/news-releases
Selected News Releases
NIH funds new All of Us Research Program genome center to test advanced sequencing tools
October 18, 2019 — HudsonAlpha awarded $7 million to expand national health dataset with uncharted genetic variants.

Candidate Ebola Vaccine Still Effective when Highly Diluted, Macaque Study Finds
October 18, 2019 — Scientists Hope Findings Mean Vaccine Supplies Could Stretch Farther.

NIH grantees win 2019 Nobel Prize in Economic Sciences
October 14, 2019 — 2019 Nobel Prize in Economic Sciences has been awarded to NIH grantees Esther Duflo and Michael Kremer, who share the prize with Abhijit Banerjee.

 

PATH [to 19 Oct 2019]
https://www.path.org/media-center/
Selected Announcements
No new digest content identified.

 

Sabin Vaccine Institute [to 19 Oct 2019]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
October 17, 2019
Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees
WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its Board of Trustees.

 

UNAIDS [to 19 Oct 2019]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
17 October 2019
Desperately seeking an HIV cure: Belgian research centre studies viral rebound

17 October 2019
Putting HIV prevention back at the centre of Brazil’s LGBTI pride

14 October 2019
Two decades of engagement in the response to HIV in Brazil

14 October 2019
New HIV infections rising in Latin America―key populations particularly affected

 

UNICEF [to 19 Oct 2019]
https://www.unicef.org/media/press-releases
Selected Statements, Press Releases, Reports
Statement
Water station in northeast Syria out of service, impacting 400,000 people as violence continues
Statement by UNICEF Representative in Syria, Fran Equiza
18/10/2019

Press release
Geneva Palais briefing note on UNICEF humanitarian support for children in northeast Syria
This is a summary of what was said by UNICEF spokesperson Marixie Mercado – to whom quoted text may be attributed – at today’s press briefing at the Palais des Nations in Geneva.
18/10/2019

Statement
UNICEF Executive Director Henrietta Fore remarks at the launch of the State of the World’s Children Report
As prepared
15/10/2019

Press release
Geneva Palais briefing note on the situation of children in northeast Syria
This is a summary of what was said by UNICEF spokesperson Marixie Mercado – to whom quoted text may be attributed – at today’s press briefing at the Palais des Nations in Geneva.
15/10/2019

Press release
Poor diets damaging children’s health worldwide, warns UNICEF
Poverty, urbanization, climate change and poor eating choices driving unhealthy diets
15/10/2019

Statement
Nearly 70,000 children displaced as violence escalates in northeast Syria
Statement by UNICEF Executive Director Henrietta Fore
14/10/2019

 

Vaccination Acceptance Research Network (VARN) [to 19 Oct 2019]
https://vaccineacceptance.org/news.html#header1-2r
No new digest content identified.

 

Vaccine Confidence Project [to 19 Oct 2019]
http://www.vaccineconfidence.org/
No new digest content identified.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 19 Oct 2019]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

 

Wellcome Trust [to 19 Oct 2019]
https://wellcome.ac.uk/news
Opinion | 16 October 2019
PhD merit needs to be defined by more than just publications
Anne-Marie Coriat
Head of UK and Europe Research Landscape Wellcome
There needs to be a change in how PhDs are assessed, with more emphasis placed on other aspects of training, to promote a positive culture for early career researchers

 

Why We Vaccinate [to 19 Oct 2019]
https://www.whywevax.org/
News
No new digest content identified.

 

The Wistar Institute [to 19 Oct 2019]
https://www.wistar.org/news/press-releases
Press Release Oct. 17, 2019
$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma
PHILADELPHIA — (Oct. 17, 2019) — The Wistar Institute and collaborating institutions have  received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.
The grant, totaling $12.5 million over five years, is a collaborative, multidisciplinary research program that supports multiple research projects contributing to the overall objectives.

 

World Organisation for Animal Health (OIE) [to 19 Oct 2019]
http://www.oie.int/en/for-the-media/press-releases/2019/
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 19 Oct 2019]
https://alliancerm.org/press-releases/
No new digest content identified.

 

BIO [to 19 Oct 2019]
https://www.bio.org/insights/press-release
Oct 14 2019
Nonpartisan Budget Experts Warn Speaker Pelosi’s Drug Pricing Bill will Stifle the Development of New Medicines
BIO’s President and CEO Jim Greenwood issued the following statement after the Congressional Budget Office released an analysis confirming that H.R. 3 will lead to fewer new medicines for patients.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 19 Oct 2019]
http://www.dcvmn.org/
Events
DCVMN 20th Annual General Meeting
21 October 2019 to 23 October 2019
Rio de Janeiro / Brazil

 

IFPMA [to 19 Oct 2019]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.

 

PhRMA [to 19 Oct 2019]
http://www.phrma.org/
Selected Press Releases, Statements
October 16, 2019
PhRMA Appoints New Leadership to Board of Directors
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) appointed new leadership to its board of directors. David Ricks, chairman and CEO of Eli Lilly and Company, was named chairman-elect and Ramona Sequeira, President of Takeda Pharmaceuticals, USA assumed the role of board treasurer…

 

Industry Watch [to 19 Oct 2019]
:: Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disease
October 18, 2019
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending a conditional marketing authorization for V920 Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP, live). If affirmed by the European Commission, the vaccine will be authorized under the brand name ERVEBO® (pronounced UR-VEE-BOH) and indicated for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola virus. The use of ERVEBO should be in accordance with official recommendations.
The CHMP’s recommendation, completed under accelerated assessment, will now be considered by the European Commission. If the European Commission affirms the CHMP opinion, it will grant a centralized marketing authorization with unified labeling that is valid in the 28 countries that are members of the European Union, as well as European Economic Area members, Iceland, Liechtenstein and Norway. ERVEBO is currently under review in the United States.
“This positive opinion from CHMP represents important progress towards licensure of a vaccine to provide protection from Ebola virus disease to people in areas affected by the Ebola Zaire virus,” said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “Our work would not have been possible without the efforts of countless numbers of people, especially those from the World Health Organization and many other government and non-governmental organizations, who have worked tirelessly on the development of this important vaccine. Our top priority is the achievement of registration of our German ERVEBO manufacturing site, so that licensed supply can be used to support global public health preparedness.”…